ne-sont-pas- utiles_1523050 [2] https://www.has- sante.fr/portail/upload/docs/application/pdf/ synthese_avis_alzheimer_031007.pdf [3] Bredesen DE. Reversal of cognitive decline : A novel therapeutic program. Aging (Albany NY). 2014 ; 6w707-717. Doi : 10.18632/aging.100690. [4] John G. Csernansky, Hongxin Dong, Anne M. Fagan, Lei Wang, Chengjie Xiong, David M. Holtzman and John C. Morris, Plasma Cortisol and Progression of Dementia in DAT Subjects – Am J Psychiatry. 2006 Dec ; 163(12) : 2164– 2169. Doi : 10.1176/appi.ajp.163.12.2164 [5] https://francais.medscape.com/voirarticle/3603472 [6] Costantini LC, vogel JL, Barr LJ, Henderson sT. Proceedings of the 59th Annual Meeting of the American Academy of Neurology Conference ; 28 April to 5 May 2007 ; Boston, MA. saint Paul, MN : American Academy of Neurology ; 2007. Clinical efficacy of AC-1202 (AC-1202TM) in mild to moderate Alzheimerʼs disease [7] C B. Hall, R B. Lipton, M Sliwinski, M J. Katz, C A. Derby and J Verghese – Cognitive activities delay onset of memory decline in persons who develop dementia – Neurology. 2009 Aug 4 ; 73(5) : 356–361. Doi : 10.1212/WNL. 0b013e3181b04ae3 [8] Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J,Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER) : a randomised controlled trial – Lancet. 2015 Jun 6 ; 385(9984) : 2255-63. Doi : 10.1016/ S0140-6736(15)60461-5. Epub 2015 Mar 12. 4